USP21 inhibitors are able to inhibit the deubiquitylation of MEK2 and FOXM1, which in turn down-regulates the expression of the ERK pathway and ultimately inhibits the growth of tumor cells (92). This evidence concerns the gene USP21 and neoplasm.